TNBI — Tanke Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $1.07m
- $5.56m
- $28.56m
Annual cashflow statement for Tanke Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | R2010 December 31st | C2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.019 | -0.022 | 3.69 | -3.14 | -0.229 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.006 | 0.006 | 0 | 5.8 | 3.68 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.001 | 0.002 | 0.537 | 0.616 | -5.29 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.014 | -0.013 | 4.38 | 3.65 | -1.18 |
| Capital Expenditures | — | — | -0.076 | -1.23 | -1.34 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -2.75 | -2.44 | -0.189 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -2.82 | -3.67 | -1.53 |
| Financing Cash Flow Items | — | — | -0.329 | -0.707 | 0.475 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.013 | 0.013 | -1.22 | 5.82 | 1.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0.404 | 5.48 | -1.53 |